AMENDMENT No. 6License Agreement • March 20th, 2014 • Astrazeneca PLC • Pharmaceutical preparations
Contract Type FiledMarch 20th, 2014 Company IndustryWHEREAS, there existed differences between Shionogi and AstraZeneca on the interpretation of the definition of NET SALES under the License Agreement, and on 20 July 2012, Shionogi started ICC arbitration proceedings against AstraZeneca relating to such differences (the “Arbitration Proceedings”);
DEED OF INDEMNITYAstrazeneca PLC • March 20th, 2014 • Pharmaceutical preparations • England and Wales
Company FiledMarch 20th, 2014 Industry Jurisdiction